Adoption of New Glucose-Lowering Medications in the U.S.-The Case of SGLT2 Inhibitors: Nationwide Cohort Study

Citation
McCoy RG, Dykhoff HJ, Sangaralingham L, et al. Diabetes Technol Ther 2019;21:702–12.